Chime Biologics (Wuhan) Co., Ltd, contract growth and manufacturing organisation, has accomplished over USD 190 million in its Series A+ spherical of financing led by Hong Kong’s various asset administration participant VMS Group.
Source link
Chime Biologics (Wuhan) Co., Ltd, contract growth and manufacturing organisation, has accomplished over USD 190 million in its Series A+ spherical of financing led by Hong Kong’s various asset administration participant VMS Group.
Source link